Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression-Reference-Cited by-同舟云学术

Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression

Published:2010-06 Issue:1 Volume:94 Page:167-172
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Cavagna Mario,Maldonado Luiz Guilherme Louzada,de Souza Bonetti Tatiana Carvalho,de Almeida Ferreira Braga Daniela Paes,Iaconelli Jr. Assumpto,Borges Jr. Edson

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of GnRH Antagonist in Assisted Reproduction;Ovarian Stimulation;2022-04-30

2. Comparative study on the pregnancy outcomes of in vitro fertilization–embryo transfer between patients with different ovarian responses (a STROBE-compliant article);Medicine;2019-07

3. Concomitant use of FSH and low-dose recombinant hCG during the late follicular phase versus conventional controlled ovarian stimulation for intracytoplasmic sperm injection cycles;Human Fertility;2017-03-22

4. Pituitary suppression with a GnRHa short protocol in an alternate day schedule associated with rhCG microdoses;JBRA Assisted Reproduction;2014

5. Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments;Fertility and Sterility;2013-05